Press Releases

January 18th, 2023- RevBio Receives Approval to Start a Dental Clinical Trial in Italy for its Regenerative Biomaterial

2022

December 15th, 2022- A Lowell Biotech will test its ‘bone glue’ in space, Boston Business Journal Article

December 9th, 2022- RevBio Launches an Experiment for its Regenerative Biomaterial on the International Space Station

November 15th, 2022- Novel Bone Adhesive to Fly on SpaceX CRS-26

September 20th, 2022- RevBio Receives NIH Grant to Explore the Treatment of Vertebral Compression Fractures with Its Regenerative Bone Adhesive Technology

September 15th, 2022 — RevBio Receives Approval from the U.K.’s Regulatory Authority to Initiate a Clinical Trial for an Optimized Formulation of its Dental Bone Adhesive Biomaterial

2021

October 25th, 2021– BONEZONE: RevBio Looked Below the Ocean to Find a Way to Treat Bone Fractures

April 6th, 2021 — RevBio Receives a $2 Million NIH Grant to Pursue the Treatment of Wrist Fractures with Its Innovative Bone Adhesive Technology

March 9th, 2021 RevBio Awarded Funding to Conduct an In Vivo Bone Experiment on the International Space Station

February 4th, 2021 — RevBio Enters the Animal Health Market to Help Improve Canine Dental Care

2020

August 4th, 2020 — LaunchPad Medical Rebrands as RevBio and Launches an Updated Website

July 7th, 2020  — LaunchPad Medical Initiates its First European Clinical Study

June 2nd, 2020 — LaunchPad Medical Wins a Coveted $1.8 Million Michigan-Pittsburgh-Wyss Regenerative Medicine Center Grant

May 5th, 2020 — LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures 

2019

December 19th, 2019 — LaunchPad Medical Accelerates Enrollment in its First-In-Man Clinical Study

November 6th, 2019 — LaunchPad Medical Wins NIH HEAL Grant to Reduce Opioid Use and Addiction

September 12th, 2019 — LaunchPad Medical Received FDA Approval to Initiate a Clinical Study

%d bloggers like this: